{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:52:11Z","timestamp":1791910331140,"version":"4.3.4"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>There is plenitude of information on HIV infection among pregnant mothers attending antenatal care (ANC) in sub-Saharan Africa. However, the epidemiology of HBV\u2013HIV co-infections in the same cohort is not clear despite the common route of transmission of both viruses. The aim of our study was to synthesize data on the prevalence of HBV\u2013HIV co-infection among pregnant women attending ANC in Sub-Saharan Africa to assist in the design of public health interventions to mitigate the challenge.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study was done in tandem with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) standards and the Cochran\u2019s Q test, I<jats:sup>2<\/jats:sup>statistics for heterogeneity and the prevalence were calculated using commercially available software called MedCalcs (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.medcalc.org\">https:\/\/www.medcalc.org<\/jats:ext-link>). A random effect model was used to pool the prevalence since all the heterogeneities were high (\u2265\u200978%) and P<jats:sub>het<\/jats:sub>\u2009&lt;\u20090.05 indicated significant heterogeneities. The risk factors and risk differences for HBV\u2013HIV co-infection were analyzed. Any likely sources of heterogeneity were analyzed through sensitivity analysis, meta-regression and sub-group analysis. All analyses were done at 95% level of significance and a<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05 was considered significant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The overall pooled prevalence of HBV\u2013HIV co-infection among pregnant mothers in sub-Saharan Africa was low 3.302% (95%CI\u2009=\u20092.285 to 4.4498%) with heterogeneities (I<jats:sup>2<\/jats:sup>) of 97.59% (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.0001). Within regional sub group meta-analyses, West Africa had significantly higher prevalence of 5.155% (95%\u2009=\u20092.671 to 8.392%) with heterogeneity (I<jats:sup>2<\/jats:sup>) of 92.25% (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) than any other region (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Articles published from 2004\u20132010 had significantly higher prevalence of 6.356% (95%\u2009=\u20093.611 to 9.811%) with heterogeneity (I<jats:sup>2<\/jats:sup>) 91.15% (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) compared to those published from 2011 to 2019 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The HIV positive cohort had significantly higher prevalence of HBV\u2013HIV co-infection of 8.312% (95% CI\u2009=\u20095.806 to 11.22%) with heterogeneity (I<jats:sup>2<\/jats:sup>)94.90% (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) than the mothers sampled from the general population with a prevalence of 2.152% (95% CI\u2009=\u20091.358 to 3.125%) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The overall and sub group analyses had high heterogeneities (I<jats:sup>2<\/jats:sup>\u2009&gt;\u200989%,<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) but was reduced for South Africa (I<jats:sup>2<\/jats:sup>)\u2009=\u200978.4% (<jats:italic>P<\/jats:italic>\u2009=\u20090.0314). Age, marital status and employment were independent factors significantly associated with risk of HBV\u2013HIV co-infection (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) but not extent of gravidity and education level (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). After meta-regression for year of publication and sample size for HBsAg positivity, the results were not significantly associated with HBV pooled prevalence for sample size (<jats:italic>P<\/jats:italic>\u2009=\u20090.146) and year of publication (<jats:italic>P<\/jats:italic>\u2009=\u20090.560). Following sensitivity analysis, the HBsAg pooled prevalence slightly increased to 3.429% (95% CI\u2009=\u20092.459 to 4.554%) with heterogeneity I<jats:sup>2<\/jats:sup>\u2009=\u200996.59% (95% CI\u2009=\u200995.93 to 97.14%), P\u2009&lt;\u20090.0001<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There is an urgent need for routine HBV screening among HIV positive pregnant mothers attending antenatal care in sub-Saharan Africa to establish the extent of HBV\u2013HIV co-infection in this cohort. Future studies need to investigate the putative risk factors for HBV\u2013HIV co-infection and prioritize plausible control strategies.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12985-020-01443-6","type":"journal-article","created":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T13:02:38Z","timestamp":1604754158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Sero-prevalence of human immunodeficiency virus\u2013hepatitis B virus (HIV\u2013HBV) co-infection among pregnant women attending antenatal care (ANC) in sub-Saharan Africa (SSA) and the associated risk factors: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9418-2831","authenticated-orcid":false,"given":"Hussein Mukasa","family":"Kafeero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Ndagire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ponsiano","family":"Ocama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Walusansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim","family":"Sendagire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,7]]},"reference":[{"issue":"4","key":"1443_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2217\/fvl.13.11","volume":"8","author":"M Lemoine","year":"2013","unstructured":"Lemoine M, Nayagam S, Thursz M. Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges. Futur Virol. 2013;8(4):371\u201380.","journal-title":"Futur Virol"},{"issue":"8","key":"1443_CR2","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1016\/S2352-3018(16)30087-X","volume":"3","author":"H Wang","year":"2016","unstructured":"Wang H, Wolock T, Carter A, Nguyen G, Kyu H, Gakidou E, Hay S, Mills E, Trickey A, Msemburi W, Coates M, Mooney M. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980\u20132015: the Global Burden of Disease Study 2015. Lancet HIV. 2016;3(8):e361\u201387.","journal-title":"Lancet HIV"},{"key":"1443_CR3","unstructured":"World Health Organization. Global hepatitis report. 2017."},{"key":"1443_CR4","first-page":"2016","volume-title":"Report","author":"UNAIDS. Global AIDS update,","year":"2016","unstructured":"UNAIDS. Global AIDS update, . Report. Geneva: UNAIDS; 2016. p. 2016."},{"issue":"7","key":"1443_CR5","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","volume":"16","author":"L Platt","year":"2016","unstructured":"Platt L, Easterbrook P, Gower E, McDonald B, Sabin K, McGowan C, Yanny I, Razavi H, Vickerman, . Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. P Lancet Infect Dis. 2016;16(7):797\u2013808.","journal-title":"P Lancet Infect Dis"},{"issue":"5 Suppl","key":"1443_CR6","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1002\/hep.22883","volume":"49","author":"CL Thio","year":"2009","unstructured":"Thio CL. Hepatitis B, and human immunodeficiency virus co-infection. Hepatology. 2009;49(5 Suppl):S138\u201345.","journal-title":"Hepatology"},{"issue":"6","key":"1443_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/hiv.12120","volume":"15","author":"V Mave","year":"2014","unstructured":"Mave V, Kadam D, Kinikar A, Gupte N, Bhattacharya D, Bharadwaj R, Thio C. Impact of maternal hepatitis B virus coinfection on mother-to-child transmission of HIV. HIV Med. 2014;15(6):347\u201354.","journal-title":"HIV Med."},{"issue":"40","key":"1443_CR8","doi-asserted-by":"publisher","first-page":"14598","DOI":"10.3748\/wjg.v20.i40.14598","volume":"20","author":"HY Sun","year":"2014","unstructured":"Sun HY, Sheng WH, Tsai MS, Lee KY, Chang SY, Hung CC. Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review. World J Gastroenterol. 2014;20(40):14598\u2013614.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1443_CR9","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1478-3231.2010.02218.x","volume":"30","author":"A Safir","year":"2010","unstructured":"Safir A, Levy A, Sikuler E, Sheiner E. (2010) Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome. Liver Int. 2010;30(5):765\u201370.","journal-title":"Liver Int."},{"key":"1443_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1046\/j.0004-8666.2003.00029.x","volume":"43","author":"W To","year":"2003","unstructured":"To W, Cheung W, Mok K. Hepatitis B surface antigen carrier status and its correlation to gestational hypertension. Aust N Z J Obstet Gynaecol. 2003;43:110\u201322.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"1443_CR11","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1128\/JVI.79.5.3038-3051.2005","volume":"79","author":"JJ Chang","year":"2005","unstructured":"Chang JJ, Wightman F, Bartholomeusz A, Ayres A, Kent SJ, Sasadeusz J, Lewin SR. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy. J Virol. 2005;79:3038\u201351.","journal-title":"J Virol"},{"key":"1443_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/jac\/dkp414","volume":"65","author":"K Lacombe","year":"2010","unstructured":"Lacombe K, Bottero J, Lemoine M, Boyd A, Girard PM. HIV\/hepatitis B virus co-infection: current challenges and new strategies. J Antimicrob Chemother. 2010;65:10\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"1443_CR13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/135965350901400207","volume":"14","author":"DM Iser","year":"2008","unstructured":"Iser DM, Lewin RS. The pathogenesis of liver disease in the setting of HIV\u2013hepatitis B virus co-infection. Antiviral Therapy. 2008;14:155\u201364.","journal-title":"Antiviral Therapy"},{"issue":"47","key":"1443_CR14","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1016\/j.vaccine.2013.08.028","volume":"31","author":"MI Andersson","year":"2013","unstructured":"Andersson MI, Maponga TG, Ijaz S, Barnes J, Theron GB, Meredith SA, Preiser W, Tedder RS. The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa. Vaccine. 2013;31(47):5579\u201384.","journal-title":"Vaccine"},{"key":"1443_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ijgo.2010.01.002","volume":"109","author":"S Zhang","year":"2010","unstructured":"Zhang S, Li R, Wang Y, Liu Q, Zhou Y, Hu Y. Seroprevalence of hepatitis B surface antigen among pregnant women in Jiangsu, China, 17 years after introduction of hepatitis B vaccine. Int J Gynaecol Obstet. 2010;109:194\u20137.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"1443_CR16","first-page":"86","volume":"11","author":"Q Zhang","year":"2011","unstructured":"Zhang Q, Cao G. Genotypes, mutations and viral load of hepatitis B virus and the risk of hepatocellular carcinoma. Hepatitis Monthly. 2011;11(2):86\u201391.","journal-title":"Hepatitis Monthly"},{"key":"1443_CR17","unstructured":"Wasmuth JC. HepatitisB-epidemiology, transmission and natural history. In: Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H, editors. Hepatology. Dusseldorf: Flying Publisher; 2009, p: 25\u201336."},{"issue":"3","key":"1443_CR18","first-page":"120","volume":"14","author":"PM Lar","year":"2013","unstructured":"Lar PM, Pam VK, Christopher PB, Gwamzhi L, Mawak JD. Prevalence and immune status of HIV\/HBV co-infected pregnant women. Afr J Clin Exp Microbiol. 2013;14(3):120\u20136.","journal-title":"Afr J Clin Exp Microbiol."},{"key":"1443_CR19","unstructured":"National Institute for Health and Clinical Excellence (NICE) Ante-natal Care. 2008. Routine care for healthy pregnant women. National Collaborating Center for Women's and Children's Health: 62:1\u201c454."},{"key":"1443_CR20","unstructured":"American College of Obstetricians and Gynecologists (ACOG) ACOG Practice Bulletin (2007). 86. ACOG, Washington DC: Viral Hepatitis in Pregnancy."},{"issue":"1","key":"1443_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12879-017-2422-9","volume":"17","author":"J Umutesi","year":"2017","unstructured":"Umutesi J, Simmons B, Makuza JD, Dushimiyimana D, Mbituyumuremyi A, Uwimana JM, Nsanzimana S. Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda. BMC Infect Dis. 2017;17(1):315.","journal-title":"BMC Infect Dis"},{"key":"1443_CR22","unstructured":"United Nations (UN) Country classification (2014) available at https:\/\/www.un.org\/en\/development\/desa\/policy\/wesp\/wesp_current\/2014wesp_country_classification.pdf"},{"key":"1443_CR23","first-page":"603","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assesment of the quality of non-randomised studies in meta-analysis of genome searches. Genet Epidemiol. 2010;25:603\u20135.","journal-title":"Genet Epidemiol"},{"key":"1443_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/gepi.20048","volume":"28","author":"E Zintzaras","year":"2005","unstructured":"Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28:123\u201337.","journal-title":"Genet Epidemiol"},{"key":"1443_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","volume":"28","author":"R DerSimonian","year":"2007","unstructured":"DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28:105\u201314.","journal-title":"Contemp Clin Trials"},{"key":"1443_CR26","doi-asserted-by":"crossref","unstructured":"Neyeloff JL, Fuchs CS, Moreira BL. 2012. Meta-analyses and forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res Notes 5:52","DOI":"10.1186\/1756-0500-5-52"},{"key":"1443_CR27","doi-asserted-by":"publisher","first-page":"205031211990087","DOI":"10.1177\/2050312119900870","volume":"8","author":"TA Bafa","year":"2020","unstructured":"Bafa TA, Egata AD. Sero-epidemiological patterns and predictors of hepatitis B, C and HIV viruses among pregnant women attending antenatal care clinic of Atat Hospital Southern Ethiopia. SAGE Open Med. 2020;8:2050312119900870.","journal-title":"SAGE Open Med"},{"issue":"7","key":"1443_CR28","first-page":"450","volume":"7","author":"Z Desalegn","year":"2016","unstructured":"Desalegn Z, Mihret A, Beyene HB, Yilma M, Seid Y, Tamiru W, Ebstie YA. Survey of hepatitis B virus infection and risk factors among pregnant women at public hospital in Ethiopia. Int J Biomed Res. 2016;7(7):450\u20136.","journal-title":"Int J Biomed Res"},{"key":"1443_CR29","doi-asserted-by":"crossref","unstructured":"Amsalu, A., Ferede, G., Eshetie, S., Tadewos, A., & Assegu, D. Prevalence, infectivity, and associated risk factors of hepatitis B virus among pregnant women in Yirgalem hospital, Ethiopia: Implication of Screening to Control Mother-to-Child Transmission. J Pregnancy 2018.","DOI":"10.1155\/2018\/8435910"},{"key":"1443_CR30","unstructured":"Dabsu R, Ejeta E. Seroepidemiology of hepatitis B and C virus infections among pregnant women attending antenatal Clinic in Selected Health Facilities in east Wollega zone, West Oromia, Ethiopia. BioMed Research International."},{"issue":"1","key":"1443_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1471-2334-14-118","volume":"14","author":"Y Zenebe","year":"2014","unstructured":"Zenebe Y, Mulu W, Yimer M, Abera B. Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study. BMC Infect Dis. 2014;14(1):118.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"1443_CR32","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2013.10.029","volume":"60","author":"CS Chasela","year":"2014","unstructured":"Chasela CS, Kourtis AP, Wall P, Drobeniuc J, King CC, Thai H, Jamieson DJ. Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants. J Hepatol. 2014;60(3):508\u201314.","journal-title":"J Hepatol"},{"issue":"1","key":"1443_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/1471-2334-14-180","volume":"14","author":"M Andreotti","year":"2014","unstructured":"Andreotti M, Pirillo MF, Liotta G, Jere H, Maulidi M, Sagno JB, Marazzi MC. The impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi. BMC Infect Dis. 2014;14(1):180.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1443_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-2122-x","volume":"17","author":"M Mutagoma","year":"2017","unstructured":"Mutagoma M, Balisanga H, Malamba SS, Sebuhoro D, Remera E, Riedel DJ, Nsanzimana S. Hepatitis B virus and HIV co-infection among pregnant women in Rwanda. BMC Infect Dis. 2017;17(1):1\u20137.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"1443_CR35","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1002\/jmv.21007","volume":"79","author":"MF Pirillo","year":"2007","unstructured":"Pirillo MF, Bassani L, Germinario EA, Mancini MG, Vyankandondera J, Okong P, Giuliano M. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda. J Med Virol. 2007;79(12):1797\u2013801.","journal-title":"J Med Virol"},{"issue":"1","key":"1443_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12884-017-1299-3","volume":"17","author":"J Manyahi","year":"2017","unstructured":"Manyahi J, Msigwa Y, Mhimbira F, Majigo M. High sero-prevalence of hepatitis B virus and human immunodeficiency virus infections among pregnant women attending antenatal clinic at Temeke municipal health facilities, Dar es Salaam, Tanzania: a cross sectional study. BMC Pregnancy Childbirth. 2017;17(1):109. https:\/\/doi.org\/10.1186\/s12884-017-1299-3.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1443_CR37","doi-asserted-by":"crossref","unstructured":"Bayo, P., Ochola, E., Oleo, C., & Mwaka, A. D. (2014). High prevalence of hepatitis B virus infection among pregnant women attending antenatal care: a cross-sectional study in two hospitals in northern Uganda.\u00a0BMJ Open 4(11).","DOI":"10.1136\/bmjopen-2014-005889"},{"issue":"22","key":"1443_CR38","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1016\/j.vaccine.2017.04.020","volume":"35","author":"E Seremba","year":"2017","unstructured":"Seremba E, Van Geertruyden JP, Ssenyonga R, Opio CK, Kaducu JM, Sempa JB, Ocama P. Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda. Vaccine. 2017;35(22):2937\u201342.","journal-title":"Vaccine"},{"issue":"3","key":"1443_CR39","first-page":"219","volume":"14","author":"D Ilboudo","year":"2010","unstructured":"Ilboudo D, Simpore J, Ouermi D, Bisseye C, Sagna T, Odolini S, Nikiema JB. Towards the complete eradication of mother-to-child HIV\/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa. Braz J Infect Dis . 2010;14(3):219\u201324.","journal-title":"Braz J Infect Dis"},{"issue":"6","key":"1443_CR40","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/jmv.20615","volume":"78","author":"J Simpore","year":"2006","unstructured":"Simpore J, Savadogo A, Ilboudo D, Nadambega MC, Esposito M, Yara J, Musumeci S. Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and-negative pregnant women in Burkina Faso. J Med Virol. 2006;78(6):730\u20133.","journal-title":"J Med Virol"},{"issue":"7","key":"1443_CR41","doi-asserted-by":"publisher","first-page":"e0219922","DOI":"10.1371\/journal.pone.0219922","volume":"14","author":"MT Frempong","year":"2019","unstructured":"Frempong MT, Ntiamoah P, Annani-Akollor ME, Owiredu WK, Addai-Mensah O, Owiredu EW, Sallah L. Hepatitis B and C infections in HIV-1 and non-HIV infected pregnant women in the Brong-Ahafo Region, Ghana. PloS one. 2019;14(7):e0219922.","journal-title":"PloS one"},{"key":"1443_CR42","unstructured":"Helegbe GK, Aryee PA, Mohammed BS, Wemakor A, Kolbila D, Abubakari AW, Ofosu E. Seroprevalence of malaria and hepatitis B coinfection among pregnant women in tamale metropolis of Ghana: a cross-sectional study. The Canadian journal of infectious diseases & medical microbiology= Journal canadien des maladies infectieuses et de la microbiologie medicale."},{"key":"1443_CR43","unstructured":"Ntiamoah P. The prevalence of Hepatitis B and\/or Hepatitis C virus (HBV and\/or HCV) co-infection among HIV-infected pregnant women\u00a0(Doctoral dissertation)."},{"key":"1443_CR44","doi-asserted-by":"crossref","unstructured":"Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, Combe P, ANRS 1236 DITRAME\u2010B&C Study Group. 2004. HBV and HCV prevalence and viraemia in HIV\u2010positive and HIV\u2010negative pregnant women in Abidjan, C\u00f4te d'Ivoire: The ANRS 1236 study.\u00a0J Med Virol.\u00a074(1), 34\u201340.","DOI":"10.1002\/jmv.20143"},{"key":"1443_CR45","unstructured":"MacLean, B., Hess, R. F., Bonvillain, E., Kamate, J., Dao, D., Cosimano, A., & Hoy, S. (2012). Sero-prevalence of hepatitis B surface antigen among pregnant women attending the Hospital for Women & Children in Koutiala, Mali.\u00a0South Afr Med J. 102(1)."},{"key":"1443_CR46","doi-asserted-by":"crossref","unstructured":"Ezechi OC, Kalejaiye OO, Gab-Okafor CV, Oladele DA, Oke BO, Musa ZA, Ezeobi PM. 2014. Sero-prevalence and factors associated with Hepatitis B and C co-infection in pregnant Nigerian women living with HIV Infection. Pan Afr Med J. 17(1).","DOI":"10.11604\/pamj.2014.17.197.2310"},{"issue":"6","key":"1443_CR47","first-page":"569","volume":"2","author":"EM Mbaawuaga","year":"2014","unstructured":"Mbaawuaga EM, Iroegbu CU, Ike AC, Jombo GTA. Studies on prevalence, co-infection and associated risk factors of hepatitis B virus (HBV) and Human immunodeficiency virus (HIV) in Benue State, Nigeria. Sci J Public Health. 2014;2(6):569\u201376.","journal-title":"Sci J Public Health"},{"issue":"4","key":"1443_CR48","first-page":"305","volume":"39","author":"O Adesina","year":"2010","unstructured":"Adesina O, Oladokun A, Akinyemi O, Adedokun B, Awolude O, Odaibo G, Olaleye D, Adewole I. Human immuno-deficiency virus and hepatitis B virus coinfection in pregnancy at the University College Hospital, Ibadan. Afr J Med Med Sci. 2010;39(4):305\u201310.","journal-title":"Afr J Med Med Sci"},{"key":"1443_CR49","unstructured":"Bassey EB, Moses AE, Udo SM, Umo AN. 2009 Parallel and overlapping human immunodeficiency virus, hepatitis B and C virus infections among pregnant women in the federal capital territory, Abuja, Nigeria. Online J Health Allied Sci. 8(1)."},{"issue":"6","key":"1443_CR50","doi-asserted-by":"publisher","first-page":"954","DOI":"10.4103\/2141-9248.144925","volume":"4","author":"LC Ikeako","year":"2014","unstructured":"Ikeako LC, Ezegwui HU, Ajah LO, Dim CC, Okeke TC. Seroprevalence of Human Immunodeficiency Virus, Hepatitis B, Hepatitis C, syphilis, and co infections among antenatal women in a tertiary institution in south east, Nigeria. Ann Med Health Sci Res. 2014;4(6):954\u20138.","journal-title":"Ann Med Health Sci Res"},{"issue":"1","key":"1443_CR51","first-page":"06","volume":"1","author":"NO Ojiegbe","year":"2018","unstructured":"Ojiegbe NO, Eleje GU, Nduka EC, Ikechukwu E, Okaforcha AOI. Hepatitis B virus infection and infectivity status among pregnant women in Nigeria. Hong Kong J Obstetrics Gynaecol. 2018;1(1):06\u201313.","journal-title":"Hong Kong J Obstetrics Gynaecol"},{"issue":"1","key":"1443_CR52","first-page":"23","volume":"19","author":"VU Usanga","year":"2010","unstructured":"Usanga VU, Abia-Bassey I, Udoh SM, Ani F, Archibong E. The Seroprevalence of Hepatitis B Surface Antigen (HBsAG) and Human Immuno-deficiency Virus (HIV) Among Pregnant Women in Calabar, Cross River State, Nigeria. J Med Lab Sci. 2010;19(1):23\u201330.","journal-title":"J Med Lab Sci"},{"key":"1443_CR53","doi-asserted-by":"crossref","unstructured":"Ya\u2019aba Y, Mohammed SB, Olatunji KT, Abubakar A, Usoroh M, Daniel OC, Nfongeh JF. 2019. Prevalence of hepatitis B and C among HIV infected pregnant women attending care and treatment at National Institute for Pharmaceutical Research and Development (NIPRD), Abuja, Nigeria. Microbiol Res J Int. 1\u20138.","DOI":"10.9734\/mrji\/2019\/v28i430137"},{"key":"1443_CR54","doi-asserted-by":"crossref","unstructured":"Thumbiran NV, Moodley D, Parboosing R, Moodley P. 2014. Hepatitis B and HIV co-infection in pregnant women: indication for routine antenatal hepatitis B virus screening in a high HIV prevalence setting.\u00a0SAMJ: South Afr Med J 104(4): 307\u20139.","DOI":"10.7196\/SAMJ.7299"},{"issue":"12","key":"1443_CR55","first-page":"473","volume":"4","author":"LE Abongwa","year":"2015","unstructured":"Abongwa LE, Clara AM, Edouard NA, Ngum NH. Sero-Prevalence of human immunodeficiency virus (HIV) and Hepatitis B virus (HBV) Co-Infection among pregnant women residing in Bamenda Health District, Cameroon. Int J Curr Microbiol Appl Sci. 2015;4(12):473\u201383.","journal-title":"Int J Curr Microbiol Appl Sci"},{"issue":"1","key":"1443_CR56","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1471-2393-13-158","volume":"13","author":"NJ Fomulu","year":"2013","unstructured":"Fomulu NJ, Morfaw FL, Torimiro JN, Nana P, Koh MV, William T. Prevalence, correlates and pattern of Hepatitis B among antenatal clinic attenders in Yaounde-Cameroon: is perinatal transmission of HBV neglected in Cameroon? BMC Pregnancy Childbirth. 2013;13(1):158.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"1443_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-9-62","volume":"9","author":"AK Kfutwah","year":"2012","unstructured":"Kfutwah AK, Tejiokem MC, Njouom R. A low proportion of HBeAg among HBsAg-positive pregnant women with known HIV status could suggest low perinatal transmission of HBV in Cameroon. Virol J. 2012;9(1):1\u20134.","journal-title":"Virol J"},{"issue":"1","key":"1443_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-015-1806-2","volume":"15","author":"JJN Noubiap","year":"2015","unstructured":"Noubiap JJN, Nansseu JRN, Ndoula ST, Bigna JJR, Jingi AM, Fokom-Domgue J. Prevalence, infectivity and correlates of hepatitis B virus infection among pregnant women in a rural district of the Far North Region of Cameroon. BMC Public Health. 2015;15(1):1\u20137.","journal-title":"BMC Public Health"},{"issue":"1","key":"1443_CR59","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4314\/ijbcs.v10i1.17","volume":"10","author":"RE Tanjong","year":"2016","unstructured":"Tanjong RE, Teyim P, Kamga HL, Neba ES, Nkuo-Akenji T. Sero-prevalence of Human Immunodeficiency Virus and hepatitis viruses and their correlation with CD4 T-cell lymphocyte counts in pregnant women in the Buea Health District of Cameroon. Int J Biol Chem Sci. 2016;10(1):219\u201331.","journal-title":"Int J Biol Chem Sci"},{"key":"1443_CR60","unstructured":"Dionne-Odom, J., Mbah, R., Rembert, N. J., Tancho, S., Halle-Ekane, G. E., Enah, C., Tita AT. 2016. Hepatitis B, HIV, and syphilis seroprevalence in pregnant women and blood donors in Cameroon.\u00a0Infect Dis Obstet Gynecol. 2016."},{"key":"1443_CR61","doi-asserted-by":"crossref","unstructured":"Mpody C, Thompson P, Tabala M, Ravelomanana NLR, Malongo F, Kawende B, CQI-PMTCT Study Team. 2019. Hepatitis B infection among pregnant and post-partum women living with HIV and on antiretroviral therapy in Kinshasa, DR Congo: a cross-sectional study.\u00a0PloS One, 14(5), e0216293.","DOI":"10.1371\/journal.pone.0216293"},{"key":"1443_CR62","doi-asserted-by":"crossref","unstructured":"Landes M, Newell ML, Barlow P, Fiore S, Malyuta R, Martinelli P, Tibaldi C (2008). Hepatitis B or Hepatitis C co-infection in HIV-infected pregnant women in Europe. HIV Med 9(7), 526\u201334.","DOI":"10.1111\/j.1468-1293.2008.00599.x"},{"key":"1443_CR63","unstructured":"Mave V, Kadam D, Kinikar A, Gupte N, Bhattacharya D, Bharadwi R, Thio C. 2014. Impact of maternal hepatitis B virus co-infection on mother-to-child transmission of HIV. HIV Med. 15(6), 347\u201354."},{"issue":"11","key":"1443_CR64","first-page":"1005","volume":"46","author":"S Chatterjee","year":"2009","unstructured":"Chatterjee S, Ravishankar K, Chatterjee R, Narang A, Kinikar A. Hepatitis B prevalence during pregnancy. Indian Pediatr. 2009;46(11):1005.","journal-title":"Indian Pediatr"},{"issue":"2","key":"1443_CR65","first-page":"138","volume":"1","author":"F Sahaf","year":"2007","unstructured":"Sahaf F, Tanomand A, Montazam H, Sany AA. Seroprevalence of hepatitis C, hepatitis B and HIV and co-infection among pregnant women: a retrospective study in 2006 at Malekan city, Iran. Res J Med Sci. 2007;1(2):138\u201341.","journal-title":"Res J Med Sci"},{"key":"1443_CR66","first-page":"442","volume":"17","author":"Y Madenda\u011f","year":"2007","unstructured":"Madenda\u011f Y, Madenda\u011f \u0130\u00e7: \u00c7elen \u015e, \u00dcnl\u00fc S, Dani\u015fman N. . Seroprevalence of Hepatitis B, Hepatitis C And HIV at whole obstetric and gynecologic patients who applied our hospital. J Gynecol Obst. 2007;17:442\u20136.","journal-title":"J Gynecol Obst"},{"key":"1443_CR67","first-page":"369","volume":"40","author":"F Tekay","year":"2006","unstructured":"Tekay F, \u00d6zbek E. Hepatitis B, Hepatitis C and Human Immunodeficiency Virus seropositivities in women admitted to \u015eanl\u0131urfa Gynecology And Obstetrics Hospital. Mikrobiyol B\u00fclt. 2006;40:369\u201372.","journal-title":"Mikrobiyol B\u00fclt"},{"issue":"9663","key":"1443_CR68","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","volume":"373","author":"Y-F Liaw","year":"2009","unstructured":"Liaw Y-F, Chu C-M. Hepatitis B virus infection. Lancet. 2009;373(9663):582\u201392.","journal-title":"Lancet"},{"issue":"1","key":"1443_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-3148.2009.00958.x","volume":"20","author":"CT Tagny","year":"2010","unstructured":"Tagny CT, Owusu-Ofori S, Mbanya D, Deneys V. The blood donor in sub-Saharan Africa: a review. Transfus Med. 2010;20(1):1\u201310.","journal-title":"Transfus Med"},{"key":"1443_CR70","doi-asserted-by":"crossref","unstructured":"Frambo AA, Besong JA, Peter NF, Ndumbe PM. 2014. Prevalence of HBsAg and knowledge about hepatitis B in pregnancy in the Buea Health District, Cameroon. a cross-sectional study. BMC Res Notes, 7:394.","DOI":"10.1186\/1756-0500-7-394"},{"key":"1443_CR71","doi-asserted-by":"crossref","unstructured":"Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, Eguchi K 2005. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection\u2014association between TGF- b 1 polymorphisms and hepatocellular carcinoma. J Hepatol. 42, 505\u201310.","DOI":"10.1016\/j.jhep.2004.11.026"},{"key":"1443_CR72","doi-asserted-by":"crossref","unstructured":"Gusatti, C. de S., Costi, C., Rubia, M., Halon, L., Grandi, T., Ferrari, A., Rodenbusch, R. (2016). Association between cytokine gene polymorphisms and outcome of hepatitis B virus infection in southern Brazil Association Between Cytokine Gene Polymorphisms and Outcome of Hepatitis B Virus Infection in. J Med Virol. (March).","DOI":"10.1002\/jmv.24518"},{"key":"1443_CR73","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1056\/NEJMoa013215","volume":"347","author":"H Yang","year":"2002","unstructured":"Yang H, Lu S, Liaw Y, You S, Sun C, Wang L. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002;347:168\u201374.","journal-title":"N Engl J Med"},{"key":"1443_CR74","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","volume":"130","author":"U Iloeje","year":"2006","unstructured":"Iloeje U, Yang H, Su J, Jen C, You S, Chen C. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006;130:678\u201386.","journal-title":"Gastroenterology"},{"key":"1443_CR75","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"C Chen","year":"2006","unstructured":"Chen C, Yang H, Su J, Jen C, You S, Lu S. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65\u201373.","journal-title":"JAMA"},{"key":"1443_CR76","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/1471-2334-13-328","volume":"13","author":"M Yousif","year":"2013","unstructured":"Yousif M, Mudawi H, Bakhiet S. Molecular characterization of hepatitis B virus in liver disease patients and asymptomatic carriers of the virus in Sudan. BMC Infect Dis. 2013;13:328.","journal-title":"BMC Infect Dis"},{"key":"1443_CR77","doi-asserted-by":"crossref","unstructured":"Soriano V, Mocroft A, Peters L, Rockstroh J, Antunes F, Kirkby N, de Wit S, Monforte Ad, Flisiak R, Lundgren J. Predictors of hepatitis B virus genotype and viraemia in HIV infected patients with chronic hepatitis B in Europe. J Antimicrob Chemother 2010; 65: 548\u201355","DOI":"10.1093\/jac\/dkp479"},{"key":"1443_CR78","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1053\/gast.2002.37041","volume":"123","author":"J Sanchez-Tapias","year":"2002","unstructured":"Sanchez-Tapias J, Costa J, Mas A, Bruguera M, Rodes J. Inuence of hepatitis B virus genome on the long-term outcome of chronic hepatitis B virus in western patients. Gastroenterology. 2002;123:1848\u201356.","journal-title":"Gastroenterology"},{"key":"1443_CR79","unstructured":"Kafeero MH, Sendagire H, Ocama P, Ndagire D. 2019. Host and viral factors associated with hepatitis B clinical outcomes in chronic infection-review article. Int J Pure Med Res. 4(3): 9\u201315"},{"issue":"Suppl. 1","key":"1443_CR80","first-page":"138","volume":"26","author":"Y Man-Fung","year":"2011","unstructured":"Man-Fung Y, Ching-Lung L. Treatment of chronic hepatitis B: evolution over two decades. J Gastroenterol Hepatol. 2011;26(Suppl. 1):138\u201343.","journal-title":"J Gastroenterol Hepatol"},{"key":"1443_CR81","doi-asserted-by":"publisher","first-page":"11941","DOI":"10.3748\/wjg.v21.i42.11941","volume":"21","author":"R Zampino","year":"2015","unstructured":"Zampino R, Boemio A, Sagnelli C, Alessio L, Adinolfi LE, Sagnelli E, Coppola N. Hepatitis B virusburden in developing countries. World J Gastroenterol. 2015;21:11941.","journal-title":"World J Gastroenterol"},{"key":"1443_CR82","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/QAI.0000000000000496","volume":"3","author":"L Stabinski","year":"2015","unstructured":"Stabinski L, Barnhart M, Kahn RJ, Hamm TE. Prevalence of HIV and hepatitis B virus co-infection in sub-Saharan Africa and the potential impact and program feasibility of hepatitis B surface antigen screening in resource limited settings. J Acquir Immune Defic Syndr. 2015;3:274\u201385.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1443_CR83","first-page":"8","volume":"50","author":"Sa\u00b4nchez, L., Tanaka, Y., Maldonado","year":"2007","unstructured":"Sa\u00b4nchez, L., Tanaka, Y., Maldonado, M., Mizokami, M., & Panduro, A. . Difference of hepatitis B virus genotype distribution in two groups of Mexican patients with different risk factors. High prevalence of genotype H and G. Intervirology. 2007;50:8\u201315.","journal-title":"Intervirology"},{"issue":"1","key":"1443_CR84","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s12879-018-3376-2","volume":"18","author":"ER Shao","year":"2018","unstructured":"Shao ER, Mboya IB, Gunda DW, Ruhangisa FG, Temu EM, Nkwama ML, Maro VP. Seroprevalence of hepatitis B virus infection and associated factors among healthcare workers in northern Tanzania. BMC Infect Dis. 2018;18(1):474.","journal-title":"BMC Infect Dis"},{"key":"1443_CR85","doi-asserted-by":"publisher","DOI":"10.21203\/rs.2.12164\/v1","author":"HM Kafeero","year":"2019","unstructured":"Kafeero HM, Ndagire DN, Nanyingi HN, Sendagire HS. Host genetic factors associated with hepatitis B virus infection and progression to chronic disease: A systematic review and Meta analysis. BMC Immunol. 2019. https:\/\/doi.org\/10.21203\/rs.2.12164\/v1.","journal-title":"BMC Immunol"},{"key":"1443_CR86","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s12157-013-0495-7","volume":"7","author":"R Ntagirabiri","year":"2013","unstructured":"Ntagirabiri R, Niyongabo T, Ndayiragije E, Baransaka. . The prevalence of hepatitis B in Burundi national survey. Afr J Hepatol Gastroenterol. 2013;7:199\u20132035.","journal-title":"Afr J Hepatol Gastroenterol"},{"issue":"3","key":"1443_CR87","doi-asserted-by":"publisher","first-page":"260","DOI":"10.5152\/tjg.2018.17634","volume":"30","author":"E\u00c7 Tanr\u0131verdi","year":"2019","unstructured":"Tanr\u0131verdi E\u00c7, \u00d6zkurt Z, Kad\u0131o\u011flu BG, Alay H, \u00c7al\u0131ko\u011flu O, Koca \u00d6, Kamalak Z. Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey. Turkish J Gastroenterol. 2019;30(3):260.","journal-title":"Turkish J Gastroenterol"},{"issue":"1091","key":"1443_CR88","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1136\/postgradmedj-2015-133876","volume":"92","author":"Y Furuncuoglu","year":"2016","unstructured":"Furuncuoglu Y, Bolukbas FF, Bolukbas C, Torun P, Ozturk R. Changes in the prevalence of HBV infection in pregnant women in Turkey between 1995 and 2015: a 20-year evaluation. Postgrad Med J. 2016;92(1091):510\u20133.","journal-title":"Postgrad Med J"},{"issue":"1","key":"1443_CR89","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/1743-422X-6-202","volume":"6","author":"M Mohammadi","year":"2009","unstructured":"Mohammadi M, Talei G, Sheikhian A, Ebrahimzade F, Pournia Y, Ghasemi E, Boroun H. Survey of both hepatitis B virus (HBsAg) and hepatitis C virus (HCV-Ab) coinfection among HIV positive patients. Virology J. 2009;6(1):202.","journal-title":"Virology J"},{"key":"1443_CR90","unstructured":"Nkiru EC, Edo AD, Obiora NG, Igwe CU. 2004. The seroprevalence of hepatitis B surface antigen and human immunodeficiency virus among pregnant women in Anambra State, Nigeria."},{"issue":"27","key":"1443_CR91","first-page":"205","volume":"71","author":"World Health Organization (WHO)","year":"1996","unstructured":"World Health Organization (WHO). HIV in Africa. Weekly Epidemiol Rec. 1996;71(27):205\u201312.","journal-title":"Weekly Epidemiol Rec"},{"issue":"08","key":"1443_CR92","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3855\/jidc.3243","volume":"7","author":"GI Gasim","year":"2013","unstructured":"Gasim GI, Murad IA, Adam I. Hepatitis B and C virus infections among pregnant women in Arab and African countries. J Infect Dev Countries. 2013;7(08):566\u201378.","journal-title":"J Infect Dev Countries"},{"key":"1443_CR93","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/1471-2458-10-512","volume":"10","author":"YJJ Van der Veen","year":"2010","unstructured":"Van der Veen YJJ, Voeten de Zwart HACM, Richardus JH. Awareness, knowledge and self reported test rates regarding Hepatitis B in Turkish-Dutch a survey. BMC Public Health. 2010;10:512.","journal-title":"BMC Public Health"},{"issue":"1","key":"1443_CR94","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s15010-010-0075-3","volume":"39","author":"TC Zhang","year":"2011","unstructured":"Zhang TC, Pan FM, Zhang LZ, Gao YF, Zhang ZH, Gao J, Ge R, Mei Y, Shen BB, Duan ZH, Li X. A meta-analysis of the relation of polymorphism at sites - 1082 and - 592 of the IL-10 gene promoter with susceptibility and clearance to persistent hepatitis B virus infection in the Chinese population. Infection. 2011;39(1):21\u20137.","journal-title":"Infection"},{"issue":"9\u201310","key":"1443_CR95","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10528-014-9655-8","volume":"52","author":"RM Talaat","year":"2014","unstructured":"Talaat RM, Dondeti MF, El-Shenawy SZ, Khamiss OA. Association between IL-10 gene promoter polymorphism and hepatitis B viral infection in an Egyptian population. Biochem Genet. 2014;52(9\u201310):387\u2013402.","journal-title":"Biochem Genet"},{"key":"1443_CR96","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12881-019-0903-y","volume":"20","author":"N Hoan","year":"2019","unstructured":"Hoan N, Khuyen N, Giang D. Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus. BMC Med Genet. 2019;20:201.","journal-title":"BMC Med Genet"},{"issue":"1","key":"1443_CR97","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/gene.2009.65","volume":"11","author":"YW Huang","year":"2010","unstructured":"Huang YW, Liao YT, Chen W, Chen CL, Hu JT, Liu CJ, Kao JH. Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan. Genes Immun. 2010;11(1):87\u201393.","journal-title":"Genes Immun"},{"issue":"8","key":"1443_CR98","doi-asserted-by":"publisher","first-page":"e1007981","DOI":"10.1371\/journal.ppat.1007981","volume":"15","author":"DT Claiborne","year":"2019","unstructured":"Claiborne DT, Scully EP, Palmer CD, Prince JL, Macharia GN, Kopycinski J, Douek D. Protective HLA alleles are associated with reduced LPS levels in acute HIV infection with implications for immune activation and pathogenesis. PLoS Pathog. 2019;15(8):e1007981.","journal-title":"PLoS Pathog"},{"issue":"4","key":"1443_CR99","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/apt.15887","volume":"52","author":"YH Huang","year":"2020","unstructured":"Huang YH, Liao SF, Khor SS, Lin YJ, Chen HY, Chang YH, Huang C. Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank. Aliment Pharmacol Ther. 2020;52(4):682\u201391.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7760","key":"1443_CR100","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41586-019-1200-9","volume":"570","author":"L Dwyer-Lindgren","year":"2019","unstructured":"Dwyer-Lindgren L, Cork MA, Sligar A, Steuben KM, Wilson KF, Provost NR, Biehl MH. Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017. Nature. 2019;570(7760):189\u201393.","journal-title":"Nature"},{"key":"1443_CR101","doi-asserted-by":"crossref","unstructured":"Prudden HJ, Beattie TS, Bobrova N, Ponovska-Griffiths J, Mukandavire Z, Gorgens M, et al. 2015. Factors associated with variations in population HIV prevalence across West Africa: findings from an ecological analysis. PLoS ONE 10 (12)","DOI":"10.1371\/journal.pone.0142601"},{"key":"1443_CR102","doi-asserted-by":"crossref","unstructured":"Hegdahl HK, Fylkenes KM, Sandoy IF. 2016. Sex differences in HIV prevalence persist over time: evidence from 18 Countries in sub-Saharan Africa. PLoS ONE 11(12).","DOI":"10.1371\/journal.pone.0148502"},{"key":"1443_CR103","unstructured":"UNAIDS. Gap Report. Geneva: UNAIDS, 2013."},{"key":"1443_CR104","unstructured":"Centers for Disease Control and Prevention. 2016. Advisory committee on immunization practices (ACIP). Recommended Child and Adolescent Immunization Schedules for Ages, 18."},{"issue":"28\u201329","key":"1443_CR105","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1016\/S0264-410X(01)00120-7","volume":"19","author":"KV Tsebe","year":"2001","unstructured":"Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage under-5-year-olds. Vaccine. 2001;19(28\u201329):3919\u201326.","journal-title":"Vaccine"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-020-01443-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-020-01443-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-020-01443-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T02:36:09Z","timestamp":1723862169000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-020-01443-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,7]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1443"],"URL":"https:\/\/doi.org\/10.1186\/s12985-020-01443-6","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,7]]},"assertion":[{"value":"19 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}